Trial
NCT02926651
Single Versus Multi-Dose Oral Tranexamic Acid in Patients at High Risk for Blood Transfusion After Total Joint Arthroplasty
Phase IVWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Rush University Medical Center
Collaborators
—
Condition
Anemia
Intervention
Conventional Oral TXA (Tranexamic Acid)
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-10-26